TARGETS AND STRATEGIES FOR THE ANTIVIRAL CHEMOTHERAPY OF AIDS

被引:103
作者
DECLERCQ, E
机构
[1] DEPT MICROBIOL,B-3000 LOUVAIN,BELGIUM
[2] REGA INST,B-3000 LOUVAIN,BELGIUM
关键词
D O I
10.1016/0165-6147(90)90115-O
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Eradication of human immunodeficiency virus (HIV) from infected cells or organisms has remained an elusive goal. In principle, any of the steps in the replicative cycle could form the basis for rational design of chemotherapeutic agents, although in practice not all have so far proved amenable to intervention. Here, Erik De Clercq summarizes the strategies that are being employed, focusing primarily on recent promising developments in inhibition of adsorption of HIV onto CD4+ T cells, and inhibition of the viral reverse transcriptase. © 1990.
引用
收藏
页码:198 / 205
页数:8
相关论文
共 37 条
  • [1] ORAL DEXTRAN SULFATE (UA001) IN THE TREATMENT OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND AIDS-RELATED COMPLEX
    ABRAMS, DI
    KUNO, S
    WONG, R
    JEFFORDS, K
    NASH, M
    MOLAGHAN, JB
    GORTER, R
    UENO, R
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (03) : 183 - 188
  • [2] NOVEL SULFATED POLYMERS AS HIGHLY POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION AND GIANT-CELL FORMATION
    BABA, M
    SCHOLS, D
    DECLERCO, E
    PAUWELS, R
    NAGY, M
    GYORGYIEDELENYI, J
    LOW, M
    GOROG, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) : 134 - 138
  • [3] MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS INVITRO
    BABA, M
    PAUWELS, R
    BALZARINI, J
    ARNOUT, J
    DESMYTER, J
    DECLERCQ, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) : 6132 - 6136
  • [4] HIGHLY SPECIFIC-INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 BY A NOVEL 6-SUBSTITUTED ACYCLOURIDINE DERIVATIVE
    BABA, M
    TANAKA, H
    DECLERCQ, E
    PAUWELS, R
    BALZARINI, J
    SCHOLS, D
    NAKASHIMA, H
    PERNO, CF
    WALKER, RT
    MIYASAKA, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) : 1375 - 1381
  • [5] BABA M, IN PRESS ACQUIRED IM
  • [6] BABA M, IN PRESS J INFECT DI
  • [7] MARKED INVIVO ANTIRETROVIRUS ACTIVITY OF 9-(2-PHOSPHONYLMETHOXY-ETHYL)ADENINE, A SELECTIVE ANTI-HUMAN IMMUNODEFICIENCY VIRUS AGENT
    BALZARINI, J
    NAESENS, L
    HERDEWIJN, P
    ROSENBERG, I
    HOLY, A
    PAUWELS, R
    BABA, M
    JOHNS, DG
    DECLERCQ, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) : 332 - 336
  • [8] BALZARINI J, 1989, J BIOL CHEM, V264, P6127
  • [9] BALZARINI J, 1989, MOL PHARMACOL, V35, P571
  • [10] DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY
    CAPON, DJ
    CHAMOW, SM
    MORDENTI, J
    MARSTERS, SA
    GREGORY, T
    MITSUYA, H
    BYRN, RA
    LUCAS, C
    WURM, FM
    GROOPMAN, JE
    BRODER, S
    SMITH, DH
    [J]. NATURE, 1989, 337 (6207) : 525 - 531